Discover

LPCN
Lipocine Inc.
1.72
3 x 1.74
1 x 2.00
bid
ask
-
0.21
10.88%
2 @ 07:58 PM
1.73 +0.01 (0.58%)
Ytd-78.58%
1y-45.40%
1.72
day range
1.90
1.72
52 week range
11.26
Open1.88Prev Close1.93Low1.72High1.90Mkt Cap14.18M
Vol1.06MAvg Vol1.72MEPS-1.85P/EN/AForward P/E-3.87
Beta1.19Short Ratio2.80Inst. Own9.96%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1450-d Avg2.16200-d Avg4.371yr Est21.50
Income Statement
Total Revenue190.10K
Revenues (USD)190.10K
Gross Profit190.10K
Operating Expenses3.03M
Research and Development Expense2.04M
Selling, General and Administrative Expense990.96K
Operating Income-2.84M
Income Tax Expense200.00
Net Income-2.62M
Net Income Common Stock-2.62M
Net Income Common Stock (USD)-2.62M
Consolidated Income-2.62M
Earnings per Basic Share-0.32
Earnings per Basic Share (USD)-0.32
Earnings per Diluted Share-0.32
Earning Before Interest & Taxes (EBIT)-2.62M
Earning Before Interest & Taxes (USD)-2.62M
Weighted Average Shares8.22M
Weighted Average Shares Diluted8.22M
Balance Sheet
Cash and Equivalents4.98M
Cash and Equivalents (USD)4.98M
Investments18.29M
Investments Current18.29M
Trade and Non-Trade Receivables190.10K
Current Assets23.74M
Property, Plant & Equipment Net74.83K
Total Assets23.84M
Current Liabilities2.07M
Total Liabilities2.07M
Accumulated Retained Earnings (Deficit)-215.69M
Accumulated Other Comprehensive Income-13.40K
Shareholders Equity21.77M
Shareholders Equity (USD)21.77M
Assets Non-Current98.58K
Deferred Revenue320.00K
Trade and Non-Trade Payables680.53K
Cash Flow
Depreciation, Amortization & Accretion14.65K
Net Cash Flow from Financing1.51M
Net Cash Flow / Change in Cash & Cash Equivalents-36.18K
Issuance (Purchase) of Equity Shares1.51M
Net Cash Flow from Investing1.48M
Net Cash Flow - Investment Acquisitions and Disposals1.48M
Net Cash Flow from Operations-3.03M
Share Based Compensation58.15K